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Abstract
Background: Regulation of bacterial gene expression by small RNAs (sRNAs) have proved to be important for many
biological processes. Francisella tularensis is a highly pathogenic Gram-negative bacterium that causes the disease
tularaemia in humans and animals. Relatively little is known about the regulatory networks existing in this organism
that allows it to survive in a wide array of environments and no sRNA regulators have been identified so far.
Results: We have used a combination of experimental assays and in silico prediction to identify sRNAs in
F. tularensis strain LVS. Using a cDNA cloning and sequencing approach we have shown that F. tularensis expresses
homologues of several sRNAs that are well-conserved among diverse bacteria. We have also discovered two
abundant putative sRNAs that share no sequence similarity or conserved genomic context with any previously
annotated regulatory transcripts. Deletion of either of these two loci led to significant changes in the expression of
several mRNAs that likely include the cognate target(s) of these sRNAs. Deletion of these sRNAs did not, however,
significantly alter F. tularensis growth under various stress conditions in vitro, its replication in murine cells, or its
ability to induce disease in a mouse model of F. tularensis infection. We also conducted a genome-wide in silico
search for intergenic loci that suggests F. tularensis encodes several other sRNAs in addition to the sRNAs found in
our experimental screen.
Conclusion: Our findings suggest that F. tularensis encodes a significant number of non-coding regulatory RNAs,
including members of well conserved families of structural and housekeeping RNAs and other poorly conserved
transcripts that may have evolved more recently to help F. tularensis deal with the unique and diverse set of
environments with which it must contend.
Background
RNA regulators are important players in control of gene
expression in bacteria and often mediate a response to
changes in the environment (for review, see [1]). Some
regulatory RNAs, designated riboswitches, are part of the
mRNA they regulate. Riboswitches are sequences in the
5’ end of mRNAs that change conformation upon bind-
ing of a ligand, affecting transcription or translation of
the down-stream gene (positively or negatively). Other
RNA regulators bind to proteins and regulate their func-
tion, whereas the largest group of small RNAs (sRNAs),
act by base pairing with target RNAs. Base pairing
sRNAs generally fall into two groups: cis-acting sRNAs
that have capacity for extensive base pairing, and trans-
encoded sRNAs with a more limited potential for base
pairing with their target RNA. Trans-acting sRNAs regu-
late the translation and/or the stability of their target
RNAs and each often regulate more than one target. For
the most part, these sRNAs affect target genes in a nega-
tive fashion by binding to the region surrounding the
start codon and ribosome binding site, but can act
through base pairing in a region far upstream, and occa-
sionally affect translation positively (for review see [1]).
Many of the trans-encoded sRNAs require the RNA cha-
perone Hfq for function. Hfq promotes RNA-RNA inter-
actions between the sRNA and its target mRNA and the
protein may additionally stabilize the sRNA in vivo.
RNA regulators furthermore control pathogenesis in
bacteria such as Staphylococcus aureus [2-6], Salmonella
typhimurium [7-10], Vibrio cholerae [11-13], group A
Streptococcus [14,15], Pseudomonas aeruginosa [16-19],
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[21,22].
Francisella tularensis is a Gram-negative bacterium
that causes the disease tularaemia in humans and in a
large number of animals and is one of the most virulent
bacterial pathogens known. The ability of F. tularensis to
invade and replicate in host cells, particularly in immune
cells such as macrophages, is critical for its capacity to
cause disease. Once inside host cells, F. tularensis resides
transiently inside a phagosome that matures into a late
endosomal stage and the bacterium then escapes to repli-
cate in the cytoplasm. The mechanism by which the bac-
terium escapes the phagosome is not well understood,
but genes encoded in a pathogenicity island (FPI) are
required for this step in the infectious cycle. Several regu-
latory proteins regulate virulence gene expression in
F. tularensis by activating transcription of the FPI. These
comprise the proteins MglA [23,24], SspA [25], PrmA
[26], and FevR (or PigR) [27,28]. F. tularensis unlike
many other bacteria encodes only one alternative sigma
factor [29], no complete two component regulator pairs
[26], and very little information exists concerning control
of gene expression apart from the above mentioned regu-
lation of the FPI.
We have recently studied the role of Hfq in the physiol-
ogy and virulence of F. tularensis [30]. Transcriptional
analyses revealed that Hfq - directly or indirectly - regu-
lates the expression of numerous genes in this pathogen.
Functional studies showed that Hfq is required for stress
resistance as well as for full virulence in both a fully viru-
lent strain and in the attenuated live vaccine strain (LVS).
Since Hfq normally performs its function by promoting
sRNA-mRNA interactions, these results strongly suggest
that sRNAs are expressed in this organism and are
involved in diverse functions. Here, we have initiated the
identification of the sRNAs expressed by F. tularensis
LVS. We have assessed and identified the sRNA species
that are expressed at high levels and found the commonly
known 4.5S RNA, 5S rRNA, and the transfer messenger
RNA (tmRNA). Additionally,w ei d e n t i f i e dt w on o v e l
sRNA species by cDNA cloning and have characterized
these. Studies of sRNA mutant strains suggested poten-
tial targets for regulation. As an alternative approach to
identify sRNAs in F. tularensis, we performed a bioinfor-
matic prediction of sRNAs. Interestingly, this analysis
found both the experimentally determined sRNA loci
and additionally identified a number of other putative
sRNA-containing intergenic regions.
Results and Discussion
Identification of highly expressed small RNA species of
Francisella
To identify sRNAs in F. tularensis we first assessed
the highly expressed sRNAs by polyacrylamide gel
electrophoresis followed by ethidium bromide staining
(Figure 1). This approach has been used successfully to
find novel sRNAs in S. aureus [31]. We isolated total
RNA from F. tularensis LVS after growth in normal
complex broth in exponential growth phase (E) or in
stationary phase (S), after oxidative stress (10 mM
H2O2) or after growth at high osmolarity (Schaedler
broth + 2% NaCl). We chose to assess the RNA profile
under different conditions because sRNA expression in
other bacteria was found to be constitutive for some
sRNAs (mostly cis-encoded sRNAs), but induced under
specific conditions (such as exposure to stress) for most
trans-encoded sRNAs [1]. However, no major differ-
ences were observed in the pattern of RNA species that
were visible after PAGE (Figure 1A). Four bands ranging
in size from ~100 nt to ~400 nt were visible after stain-
ing (Figure 1A; labeled 1-4). To determine the origin of
these four RNA species, we eluted the RNAs from the
gel and performed linker ligation, cDNA synthesis, and
PCR amplification of each eluted RNA (see Methods).
Sequence analysis of cloned PCR fragments identified
the RNAs, although in all cases we also found contami-
nating rRNA and/or tRNA sequences.
Ten clones corresponding to RNA #4, the largest RNA,
were sequenced and seven of these identified the RNA as
the transfer messenger RNA (tmRNA; FTL_R001). This
RNA is also designated SsrA and is 421 nt in size.
tmRNAs are found in all bacteria and are highly
expressed. The tmRNA has properties of both a tRNA
and a mRNA. It participates in trans-translation, which is
a reaction that transfers the translational complex to the
tmRNA and ultimately leads to degradation of the poly-
peptide (for review, see [32]).
Based on the size of RNA #2, we presumed it was the
5S rRNA (114 nt). This was confirmed after cDNA
sequencing. Next, RNA #1 was identified as the 4.5S
RNA component of the signal recognition particle
(FTL_R0044; 108 nt). FTL_R0044 was found in one of
ten clones sequenced, whereas the other nine clones
were the 5S rRNA. This is not very surprising consider-
ing the very similar size of these two transcripts and the
high expression of the 5S RNA. Despite several
attempts, we did not obtain any cDNA clones of RNA
#3, the RNA with an apparent size of ~200 nt.
Cloning and identification of additional sRNAs
As our analysis of highly expressed RNA did not result
in the identification of novel small RNA transcripts, we
proceeded to construct a limited cDNA library of low
molecular weight RNAs. For this, we used the same
approach as described for the highly expressed sRNAs.
Total RNA from bacteria grown under the different
conditions described above, but depleted of ribosomal
RNAs (16S and 23S rRNA), was separated on a 8%
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mately 100-200 nt were eluted from the gel and pro-
cessed the same way as for the highly expressed RNAs.
The gel was divided into smaller areas before eluting
the RNAs and ten clones from each area (shown in
Figure 1B) were sequenced in order to identify new
sRNA species. By this method, we identified two differ-
ent RNAs, one of which was identified twice from the
same gel piece, whereas the remaining clones contained
rRNA, tRNA or other contaminating sequences.
To further confirm that the two identified candidates
are authentic sRNAs, we performed Northern blotting
analysis (Figure 2) using
32P-labeled oligonucleotides as
probes. As can be seen in Figure 2, a strong band was
observed for each of the sRNA candidates with sizes of
approximately ~70 nt and ~110 nt, respectively. We
refer to these sRNAs as FtrA and FtrB for Francisella
tularensis sRNA A and B. In addition to the major
bands, two bands of larger size were seen for FtrA and
one with a lower size for FtrB, suggesting that proces-
sing of the transcripts might be occurring.
sRNA mapping, localization, and structure analysis
To map the ends of the RNAs we performed 5’-a n d
3’-RACE (Table 1). This revealed that FtrA is 111 nt and
FtrB is 115 nt in length. The size found for FtrB is in
Figure 1 Experimental identification of F. tularensis sRNAs. (A) Total RNA extracted at exponential phase (E), stationary phase (S), high salt
concentration (NaCl) or after exposure to oxidative stress (H2O2) analyzed by 8% PAGE and stained by ethidium bromide (M, RNA marker).
Individual bands processed for cloning are indicated by numbers. (B) Schematic representation of gel used for cloning of cDNA. Each square
denotes a piece that was individually processed for RNA extraction and A and B designate the area from which FtrA and B were identified,
respectively. For clarification, the highly expressed RNAs (#1-3) seen in (A) are indicated.
Figure 2 Northern blots verify the presence of F. tularensis
sRNAs. RNA extracted from F. tularensis LVS (1) or mutant (2)
bacteria in exponential phase was analyzed by Northern blotting
using
32P-labeled oligonucleotides as probes (ProbeA specific for
FtrA and ProbeB specific for FrtB). Approximate sizes are indicated
based on RNA Marker and location of dyes in the gel.
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blot, whereas it seems to correspond to one of the larger,
but less intense, bands seen in the Northern blot of FtrA.
The ftrA gene is located between FTL_1319 and
FTL_1320 (Table 1 and Figure 3) and is encoded on the
coding strand. The flanking genes encode a transposase
and a conserved hypothetical protein. FtrB is encoded on
the coding strand between FTL_0035 and FTL_0036,
encoding two hypothetical proteins. The predicted second-
ary structures of FtrA and FtrB, using the Quikfold pro-
gram http://dinamelt.bioinfo.rpi.edu/quikfold.php[33,34],
are shown in Figure 3. Both FtrA and FtrB are predicted
to be highly structured and contain several stem-loops.
To determine whether FtrA and FtrB are similar to
known bacterial sRNAs, we performed BLAST to search
the sequences of the non-coding RNA database http://
ncrnadb.trna.ibch.poznan.pl/blast.html. No bacterial
RNAs in the database showed sequence similarity to the
two F. tularensis sRNAs. Sequences were also queried
against the Rfam database http://rfam.sanger.ac.uk/,
which did not result in any matches. Furthermore, a
BLASTN search of the genes encoding either sRNA
against the NCBI total sequence database showed that
the genes are only found in Francisella and not in any
other bacterial genome. This strongly indicates that the
two RNAs are novel bacterial sRNAs.
Characterization of ftrA or ftrB mutants
To study the role of the sRNAs, we proceeded by creat-
ing mutant strains carrying a chromosomal deletion of
either the ftrA or ftrB gene. Sequencing and Northern
blotting were respectively used to confirm deletion of
these loci and the absence of their corresponding tran-
scripts (Figure 2). Neither mutant strain exhibited any
growth defects or increased sensitivity to several stress
conditions (H2O2, ethanol, low pH, NaCl; data not
shown), showing that deleting either ftrA or ftrB does
not affect the ability of F. tularensis to survive a number
of stresses. Likewise, we did not observe any change in
expression of either FtrA or FtrB after exposure to oxi-
dative or osmolarity stress (data not shown).
We next tested if either gene plays a role in F. tular-
ensis intracellular multiplication. As shown in Figure 4,
both mutant strains multiplied intracellularly in J774
murine macrophage-like cells in a manner indistinguish-
able from the wild-type strain, indicating that neither
FtrA nor FtrB is required for multiplication in macro-
phages in vitro.
To examine if FtrA or FtrB is required for virulence of
F. tularensis, we assessed the ability of each mutant
strain to induce disease in the mouse model of infection.
No major difference in survival was observed between
mice infected with wild-type LVS or with either of the
mutant strains, showing that neither gene is required for
virulence (data not shown). In addition, after infecting
mice with a 1:1 mixture of mutant and wild-type bac-
teria we recovered equal numbers of wild-type and
mutant bacteria from the spleen (data not shown). This
further demonstrates that deleting ftrA or frtB does not
affect F. tularensis pathogenicity in the mouse model.
It is important to recall that most sRNAs affect gene
expression negatively. Deleting a specific sRNA gene
and thus alleviating the repressive effect may not be of
major consequence for the bacterium. Our results from
in vitro characterization of the mutant strains therefore
do not rule out the possibility that FtrA or FtrB may
indeed control functions related to growth, stress resis-
tance or virulence.
Identification of potential targets
Most characterized sRNAs control expression of their
target genes by base-pairing with a target mRNA. In
addition to affecting translation, base-pairing between a
sRNA and its target frequently leads to changed stability
of both sRNA and mRNA. Therefore, to experimentally
identify potential targets for regulation by FtrA and FtrB,
we compared the transcriptomes of LVS wild-type bac-
teria grown in regular broth to that of either the ftrA or
the ftrB mutant. This way we identified several potential
targets for FtrA and FtrB (Table 2). None of the potential
targets identified by microarray analysis are located in
the same genomic region as the sRNAs, indicating that
the sRNAs are trans-acting. The analysis identified four
genes for which the transcript was found at a higher level
in the ftrA mutant than in LVS. These are FTL_0045
(encoding orotidine 5’-phosphate decarboxylase, PyrF),
FTL_0207 (encoding pyrrolidone carboxylate peptidase,
Pcp), FTL_0902 (encoding an oxidoreductase), and
FTL_1922 (encoding a YggT family protein). Interest-
ingly, pyrF transcripts were also found at higher levels in
a hfq mutant [30]. Thus, deleting either hfq or ftrA affects
pyrF mRNA levels in the same manner, in agreement
with a regulatory mechanism in which Hfq-mediated
FtrA-pyrF mRNA base-pairing leads to degradation
of the target mRNA. This, however, needs to be
Table 1 Small RNAs identified by cDNA cloning
sRNA 5’ end
a 3’ end
b Length
(nt)
Flanking
genes
Genomic
context
c
FtrA 1256577 1256687 111 FTL_1319-
FTL_1320
>><
FtrB 37655 37769 115 FTL_0035-
FTL_0036
>>>
a Coordinate of the 5’ end of sRNA (determined by 5’-RACE).
b Coordinate of the 3’ end of sRNA (determined by 3’-RACE).
c The orientation of the sRNA and its flanking genes (in order of gene
numbers). “>“ designates a gene encoded on the coding strand and “<”
designates a gene encoded on the non-coding strand.
Postic et al. BMC Genomics 2010, 11:625
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genes were changed in the ftrB mutant compared to
wild-type bacteria: two were found in higher levels
(FTL_0836 and FTL_1754)a n dt h r e ea tl o w e rl e v e l s
(FTL_0324, FTL_0421 and FTL_1966)i nt h eftrB mutant.
Of these, FTL_0421 (encoding a lipoprotein) was also
found to be down-regulated in the F. tularensis hfq
mutant [30]. This finding could be explained by a
mechanism in which RNA duplex formation leads to sta-
bilization of the mRNA. To confirm the results obtained
by microarray analysis, we chose two genes with changed
expression in either mutant strain and performed quanti-
tative RT-PCR analysis. For each mutant strain, this ana-
lysis confirmed the change in expression for both genes
(see Additional File 1). Presently we do not know if FtrA
and FtrB regulate these targets directly as it is also possi-
ble that the observed changes in mRNA level are due to
indirect effects of deleting the sRNA.
Identification of putative sRNAs using bioinformatics
analysis
While our cloning based screen proved effective in iden-
tifying previously unknown sRNAs, the relatively small
number of clones sequenced meant that only abundant
Figure 3 Characterization of the two F. tularensis sRNAs. Schematic representations of the genomic positions of the ftrA (A) and ftrB (B) loci
are shown at top in each section. The DNA sequence of the regions, with the sRNA gene indicated in bold and proposed -10 and -35 boxes
underlined, are shown below. The secondary structure predictions of FtrA and FtrB using Quikfold (RNA 3.0) are shown in (C).
Figure 4 Intracellular macrophage multiplication of sRNA
mutants. The number of intracellular bacteria was followed for 48
hours after infection of murine macrophage-like cells J774 by F.
tularensis LVS wild-type or sRNA mutants ftrA or ftrB.
Postic et al. BMC Genomics 2010, 11:625
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an effort to identify putative sRNAs in F. tularensis that
may have been missed in our physical screen, we used
the bioinformatic tool SIPHT [35] to conduct a gen-
ome-wide bioinfomatic screen for candidate sRNAs in
F. tularensis LVS. SIPHT identifies candidate intergenic
loci based on the co-localization of intergenic conserva-
tion and Rho-independent terminators. It then annotates
these candidates for several features, including the simi-
larity of their primary sequence and predicted secondary
structure to intergenic sequences in other bacterial
replicons, their proximity to the putative binding sites of
various transcription factors, and their homology to pre-
viously confirmed or predicted sRNAs and cis-regulatory
RNA elements.
A total of 24 candidate loci were identified by SIPHT,
including three intergenic regions (IGRs) each contain-
ing two overlapping candidate loci, leading to a total of
21 IGRs (Table 3 and Additional File 2). Importantly,
both the FtrA and FtrB sRNA were identified in the
bioinformatic prediction (Table 3, candidate 19 (FtrA)
and candidate 14 (FtrB)), suggesting that other candidate
loci identified by SIPHT may represent real non-coding
RNAs. One of these candidates was annotated by
SIPHT as sharing sequence homology with SprB, a pre-
viously identified but uncharacterized sRNA in Staphylo-
coccus aureus [31], while another was found in a similar
genomic location based on its flanking genes to P26, an
sRNA of unknown function in Pseudomonas aeruginosa.
For fourteen of the loci identified, including FtrA and
FtrB, conservation of secondary structure was predicted
by QRNA [36]. Putative sigma-70 promoters were iden-
tified within 400 nucleotides upstream of the predicted
terminators of 9 candidates, including two upstream of
ftrA, one of which in a position consistent with the lar-
ger band seen by Northern analysis and the results of
the 5’-RACE.
Neither tmRNA nor 4.5S RNA were identified by
SIPHT. Further analysis revealed that these loci were
missed because they were not associated with predicted
Rho-independent terminators. This may reflect a true
paucity of Rho-independent terminators in F. tularensis
or limitations in the ability of the three terminator pre-
dicting algorithms used by SIPHT to identify termina-
tors in an AT rich genomes such as that of F. tularensis.
The fact that these two sRNAs were not identified by
SIPHT suggests that other F. tularensis sRNAs were
likely missed in our screen.
Several characteristics of Francisella likely hinder pre-
dictions of sRNAs based on the proximity of intergenic
sequence conservation and Rho-independent termina-
tors. First, no genome sequences for close relatives of
F. tularensis are available for BLAST comparisons and
the relatively low GC content (32%) of the F. tularensis
genome leads to spurious hits in BLAST searches that
are more likely due to low sequence complexity than to
actual sequence conservation. Second, as described
above, it is also likely that existing terminator prediction
programs, most of which had been trained on E. coli,
are less effective in identifying terminators in AT-rich
species such as Francisella. Indeed, in a kingdom-wide
search for putative sRNAs in over 500 different strains,
all Francisella sp. were among the 20 strains with the
lowest density of putative intergenic Rho-independent
terminators. However, while these factors likely contri-
bute to both the decreased sensitivity and specificity of
our sRNA predictions, the fact that both FtrA and FtrB
were identified in our in silico screen suggests that the
predictive algorithm used by SIPHT is effective in iden-
tifying novel sRNAs even in species such as Francisella
that are AT-rich and have relatively few sequenced
relatives.
Recently, a number of small ORFs encoding small
peptides (<50 amino acids), previously non-annotated,
have been identified in other bacterial species [37,38].
We therefore examined whether the predicted sRNA
loci in F. tularensis contain ORFs encoding small pep-
tides (Table 3). A few loci could encode small peptides
Table 2 Effect of ftrA and ftrB deletion on the transcriptome of LVS
Locus
a Gene product Fold-change in ftrA
b Fold change in ftrB
b
FTL_0045 orotidine 5’-phosphate decarboxylase 1.8 NA
FTL_0207 pyrrolidone-carboxylate peptidase 2.6 NA
FTL_0902 oxidoreductase 1.8 NA
FTL_1922 YggT family protein 10.8 NA
FTL_0324 pseudogene NA 0.7
FTL_0421 lipoprotein NA 0.7
FTL_0836 hypothetical protein NA 8.2
FTL_1754 hypothetical membrane protein NA 1.5
FTL_1966 anthranilate synthase component I NA 0.7
a Genes included had ≥1.5 average fold-change in mRNA level (calculated for all spots) and for which each of the five spots for the gene on the microarray had
fold-changes ≥1.2
b Change in mRNA level in mutant strain compared to wild-type LVS
Postic et al. BMC Genomics 2010, 11:625
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only very short ORFs, further supporting the hypothesis
that the majority of the loci encode putative RNAs.
Conclusions
Here, we have confirmed the expression in F. tularensis
of the well-known non-coding RNAs tmRNA and 4.5S
RNA after direct purification and cloning of the cDNAs.
Two additional sRNAs expressed by F. tularensis were
identified from a cDNA library prepared from low mole-
cular weight RNA. The two putative sRNAs (called FtrA
and FtrB), which are encoded in intergenic regions,
were confirmed to be genuine sRNAs by Northern blot
analysis and the transcripts were characterized with
respect to transcription endpoints. The sRNAs do not
show sequence similarity to any known sRNAs and their
DNA sequences are only found in Francisella species,
indicating that these are novel sRNAs. Deletion of either
the ftrA or ftrB gene had no effect on bacterial survival
during normal growth or stress, and did not affect the
capacity of Francisella to induce disease in mice. This
suggests that these sRNAs affect functions that are not
required under the conditions tested or that additional
sRNAs with redundant functions may exist. Specifically,
in silico analysis identified conserved sequence between
FtrB and sRNA candidate #20 (Table 3) suggesting they
may be functional paralogues. Subsequently, microarray
analysis allowed us to identify a number of potential tar-
gets of FtrA and FtrB regulation. Further experiments
will be needed to verify if these represent real targets.
Finally, in silico prediction of putative sRNA loci identi-
fied a number of Francisella IGRs, including the two
harboring ftrA and ftrB. Future work will determine
which of these IGRs indeed encode authentic sRNAs.
Methods
Bacterial growth and plasmids
All strains and plasmids used in this study are listed in
Table 4. F. tularensis LVS was grown in Schaedler broth
supplemented with vitamin K3 (Biomérieux, France), on
chocolate agar plates supplemented with IsoVitalex vita-
m i ns o l u t i o n( B i o m é r i e u x ,F r a n c e ) ,o ri nd e f i n e d
Table 3 Putative sRNAs predicted in silico
a
RNA Length (nt) Coordinates Flanking genes Genomic context
b Potential ORFs
c
1 39 599871-599910 FTL_0609-FTL_0610 >68|>|984< -
2 91 865504-865595 FTL_0886-FTL_0887 <1|>|129> 1
3 168 1039023-1039191 FTL_1090-FTL_1091 <4|>|-32> 8, 12*
4 141 1567719-1567860 FTL_1636-FTL_1637 >557|>|488< 2*
5 41 1808414-1808455 FTL_1875-FTL_1876 <349|<|203< 2, 8*
6 89 1251973-1252062 FTL_1313-FTL_1314 >145|<|47< -
7 181 1240899-1241080 FTL_1303-FTL_1304 >26|<|0< 41
8 125 765395-765520 FTL_0777-FTL_0778 >132|<|0> 2
9 87 508319-508406 FTL_0527-FTL_0528 >149|<|0> -
10 225 508181-508406 FTL_0527-FTL_0528 >11|<|0> 52*, 32, 37
11 191 361680-361871 FTL_0391-FTL_0392 <476|<|331< -
12 229 133934-134163 FTL_0131-FTL_0132 <141|<|29< 3
13 92 52224-52316 FTL_0050-FTL_0051 <54|<|0< 7*, 2
14 177 37528-37705 FTL_0035-FTL_0036 >1|>|209> 10*, 4, 24*, 2
15 122 359671-359793 FTL_0389-FTL_0390 >1|>|176< 19, 2, 2
16 390 511941-512331 FTL_0529-FTL_0530 >1|>|-32< 9*, 4*, 7, 41, 7, 16*
17 52 527019-527071 FTL_R0021-FTL_0544 <2|>|8< -
18 36 1251854-1251890 FTL_1313-FTL_1314 >26|<|219< -
19 196 1256490-1256686 FTL_1319-FTL_1320 >57|>|128< 8, 9, 13
20 213 1351294-1351507 FTL_1420-FTL_1421 >67|<|0< 11, 19, 24*
21 119 1681442-1681561 FTL_1744-FTL_1745 <33|<|0< 15*, 3*
22 292 1229654-1229946 FTL_R0033-FTL_1289 >2|>|462< 10, 13*, 2, 11
23 228 49421-49649 FTL_0046-FTL_0047 >80|<|49< 2*, 11, 12*, 20
24 240 765280-765520 FTL_0777-FTL_0778 >17|<|0> 12*, 2, 33*
a sRNA candidates, 5’ and 3’ ends predicted using SIPHT [35].
b The orientation of the sRNA and its flanking genes (in order of gene numbers). “>“ designates a gene encoded on the coding strand and “<” designates a gene
encoded on the non-coding strand. Numbers outside of the “|” characters denote the distance between the boundaries of the predicted locus and its flanking
genes.
c Potential ORFs are indicated by their length in amino acids. * denotes an ORF staring with an alternative start codon.
For sequence of each RNA see Additional File 2.
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needed, media was supplemented with kanamycin (50
μgm l
-1 for E. coli and 10 μgm l
-1 for F. tularensis). Oli-
gonucleotides used are described in Table 5.
Bioinformatic prediction of sRNA loci
Candidate sRNAs were predicted using the SIPHT pro-
gram, as described previously [35]. Thresholds for
BLAST E value, RNAMotif score, FindTerm score, and
TransTerm confidence were set to 5e-3, -6, -10, and 86,
respectively. All other parameters were set to default
values.
Extraction of RNA for gel fractionation
LVS was grown to mid-exponential phase or to station-
ary phase in Schaedler-K3 before harvesting the bacteria.
For oxidative stress experiments, bacteria at OD600 = 0.3
were exposed to 10 mM H2O2 for 30 min before har-
vested. For experiments at high osmolarity, LVS was
g r o w ni nc o m p l e xm e d i u mc o n t a i n i n g2 %N a C lt o
OD600 = 0.3 before being harvested. Total RNA was
extracted using Trizol reagent (Invitrogen) according to
the protocol provided by the manufacturer and treated
with Turbo DNase (Ambion). For cDNA library con-
struction, total RNA was depleted of 16S and 23S
rRNAs using the MICROBExpress kit (Ambion) accord-
ing to the protocol provided by the manufacturer before
loaded on gel.
RNA elution and cDNA cloning
20 μg of total RNA was heated and loaded onto an 8%
polyacrylamide/8M urea gel with the RNA Century Plus
(Ambion) as size marker. After separation, the gel was
stained with ethidium bromide and a gel piece contain-
ing RNA of a certain size was cut out. RNA was eluted
from the gel after crushing and incubation at 37°C in
0.5 M ammonium acetate and 1 mM EDTA (pH 8.0)
for 6 hours under constant agitation. Supernatants were
extracted once with chloroform before precipitation of
the RNA with isopropanol in the presence of glycogen.
Next, 3’ adapter was ligated to the dissolved RNA with
T4 RNA ligase in the presence of DMSO and RNase
inhibitor for 90 min at 37°C. The RNA was purified
from a 15% polyacrylamide/urea gel as described above
to remove non-incorporated adapters. The eluted RNA
was treated with tobacco acid phosphatase (TAP) before
ligation of 5’ adapter (using the same method as for 3’
adapters) and subsequently non-incorporated adapters
r e m o v e db yp a s s i n ga n dt w i c ew a s h i n gt h eR N Ao na
Microcon YM-30 (Millipore) column. The RNA was
reverse transcribed using the 3’PRIMER and SuperScript
II reverse transcriptase (Invitrogen), PCR amplified
using 5’PRIMER and 3’PRIMER and ligated into
pCR2.1-TOPO. All RNAs were identified using this pro-
tocol, except the tmRNA for which we used a protocol
that ligates the 3’adapter before the 5’adapter and uti-
lizes different adapters (adapters B; see Table 5).
Northern blot
Total RNA was extracted using Trizol according to the
manufacturer’s instructions (Invitrogen) and quantified
on a NanoDrop ND-1000 Spectrophotometer (Thermo
Scientific). After extraction, 10 μg of total RNA were
loaded on a polyacrylamide gel (8% acrylamide/8M
urea). After migration, theR N Aw a st r a n s f e r r e dt oa
Hybond-N+ membrane (Amersham) and crosslinked
with UV light. The membrane was prehybridized in
Rapid-Hyb Buffer (Amersham). Then,
32P-labelled gene-
specific probe (oligonucleotide, see Table 5) was added
directly to the prehybridization buffer with the mem-
brane and incubated for 16 hours at 42°C. After hybridi-
zation, the membrane was washed twice with 2×SSC/
Table 4 Bacterial strains and plasmids
Strain or plasmid Description Source or reference
Strain
F. tularensis
LVS subsp. holarctica, live vaccine strain A. Sjöstedt
LVSΔftrA LVS with deletion of ftrA This study
LVSΔftrB LVS with deletion of ftrB This study
E. coli
DH5a Strain collection
Plasmid
pCR2.1-TOPO PCR cloning vector, Km
R, Amp
R Invitrogen
pMP812 sacB suicide vector, Km
R [40]
pMP-ΔftrA pMP812 containing ~2 kb fragment for deletion of ftrA This study
pMP-ΔftrB pMP812 containing ~2 kb fragment for deletion of ftrB This study
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Page 8 of 120.1% SDS, once with 1×SSC/0.1% SDS and twice with
0.1×SSC/0.1% SDS. Results were analyzed on a Storm
860 PhosphorImager (Molecular Dynamics) using the
ImageQuant software (Molecular Dynamics).
5’- and 3’-RACE
For 5’-RACE, 15 μg of total RNA was incubated with
TAP for 2 hours at 37°C after which 5’ adapter was
ligated with RNA ligase. RNA was purified from gel and
reverse transcribed with a gene specific primer and
SuperScript II RT. cDNA was then used as a template
in PCR reaction with the 5’PRIMER and the gene speci-
fic primer (GSP_5’RACE) and cloned into pCR2.1-
TOPO before sequencing.
3’-RACE was performed by ligating the 3’ adapter to
total RNA, followed by gel purification of adapter ligated
RNA, reverse transcription with 3’PRIMER and finally
conducting PCR with 3’PRIMER and GSP_3’RACE. The
3’ end of each sRNA was determined by sequencing of
cloned PCR products in pCR2.1-TOPO.
Table 5 Oligonucleotides used in this study
Oligonucleotide Sequence (5’ to 3’ direction)
a Use
3’ adapter P-
-rUrUrUCGGGCCGCGGACTGTidT cDNA cloning and RACE
5’ adapter GATATGCGCGAATTCCTGTAGAACGAACACTAGGGGrArArA cDNA cloning and RACE
5’PRIMER GTAGAACGAACACTAGGGGAAA cDNA cloning and RACE
3’PRIMER GACAGTCCGCGGCCCGAAA cDNA cloning and RACE
3’ adapter_B P-rUrUrUCTATCCATGGACTGTidT cDNA cloning tmRNA
5’ adapter_B GATATGCGCGAATTCCTGTAGAACGAACACTAGAAGrArArA cDNA cloning tmRNA
5’PRIMER_B GTAGAACGAACACTAGAAGAAA cDNA cloning tmRNA
3’PRIMER_B TACAGTCCATGGATAGAAA cDNA cloning tmRNA
ftrA_GSP_5’RACE GTTATTCAGACGTGTCAAACAGAG 5’-RACE ftrA
ftrA_GSP_3’RACE GTACCAAATAATTAATGCTCTGTAATC 3’-RACE ftrA
ftrB_GSP_5’RACE GAGATTCCCGCCTACGCGG 5’-RACE ftrB
ftrB_GSP_3’RACE GATACTAACTTAACGTCGGTAGTC 3’ RACE ftrB
ftrA_DelR GCGCGGCCGCGTGGTAAAATCATCTAGGTTCTAGC Deletion ftrA
ftrA_DelB CATTTATAATTTTAGATATTTTTTCGC Deletion ftrA
ftrA_DelO GCGAAAAAATATCTAAAATTATAAATGGGCAATTAATATATCTTGTTCGCTTCTTAGC Deletion ftrA
ftrA_DelT GCGTCGACGCAACTAAGAAAAGAATATTTAATAGCC Deletion ftrA
ftrA_DelCheck1 CATATGTAGTGTACTTTATTTAAATAC Verification of ftrA deletion
ftrA_DelCheck2 CCTAAGTTTCAGTTGCTGAATTATTTGG Verification of ftrA deletion
ftrA_DelCheck3 GCCACTGAAGGCGGAAATCTCGC Verification of ftrA deletion
ftrA_DelCheck4 CAGTTAAATATTATTAACATTAAGAAAC Verification of ftrA deletion
ftrB_DelR GCGCGGCCGCCTTTTAAGATTTGTATTCTTATTTGTTC Deletion ftrB
ftrB_DelB CACTACCCCGTATTGCTTCGCAAGCC Deletion ftrB
ftrB_DelO GGCTTGCGAAGCAATACGGGGTAGTGCCTAAGGAGTCAAACTAACAAAGGGGCCTGC Deletion ftrB
ftrB_DelT GCGTCGACCAGAGCATTTATGATAGTTTGTTTTCC Deletion ftrB
ftrB_DelCheck1 CTAAATCTAAGGAATGATAATTAACC Verification of ftrB deletion
ftrB_DelCheck2 GGACAGGAATGGACAGCAGAAG Verification of ftrB deletion
ftrB_DelCheck3 GTATATCCTATTTGAAAAGCTAATGGC Verification of ftrB deletion
ftrB_DelCheck4 CACTATATGGATATGCTTATGAACAAGC Verification of ftrB deletion
ProbeA CAGACGTGTCAAACAGAGGTCCGTTCAAAATAC Northern blot
ProbeB GAGATTCCCGCCTACGCGGGAATGACTACCGACG Northern blot
FTL_0044_F GCTATATGTCCCAGGTGTAAGG qRT-PCR
FTL_0044_R GCTCTTTGGCTTTTTTAGGGGTC qRT-PCR
FTL_0421_F GGGCAACTGTAACAGTTAAGC qRT-PCR
FTL_0421_R CTTCTTTGTCATAAACTACATTAGC qRT-PCR
FTL_0836_F GTGGCTATTGATGACATACTCAAC qRT-PCR
FTL_0836_R GCTAAGCCTAGATAACTGATACC qRT-PCR
FTL_1922_F GGATTTGATTTTTCTCCAATTATTG qRT-PCR
FTL_1922_R CTGCGCAATAATGCTTTGTATG qRT-PCR
a Bases preceded by r designates a ribonucleotide whereas all other are deoxyribonucleotides. idT designates an inverted deoxythymidine. P designates a
phosphorylated 5’ end. NotI site is underlined. SalI site is shown in italics.
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Regions of approximately 1 kb upstream and down-
stream of ftrA and ftrB were amplified by PCR using
primer pairs DelR/DelB and DelO/DelT. The upstream
and downstream fragments were purified from gel,
annealed and extended in 20 cycles of PCR without pri-
mers and the product further used as template in a PCR
reaction with primers DelR and DelT. The ~2 kb PCR
products were cloned into pCR2.1-TOPO (Invitrogen)
and mobilized as a NotI-SacIf r a g m e n ti n t ot h esacB
based suicide vector pMP812 [40] creating pMP-ΔftrA
and pMP-ΔftrB.p M P - ΔftrA and pMP-ΔftrB were intro-
duced in LVS by electroporation and integration of the
plasmid into the chromosome confirmed by PCR.
Strains were then passed once in medium without selec-
tion, subsequently streaked on solid medium containing
6% sucrose and isolated colonies were tested for loss of
the gene by PCR (using primer pairs DelCheck1/Del-
Check4 and DelCheck2/DelCheck3). Deletion of the
gene was confirmed by sequencing.
cDNA labeling and microarray hybridizations
RNA used in microarray experiments was extracted
using Trizol reagent combined with purification of the
aqueous phase on RNeasy columns (Qiagen). cDNA
labeling and microarray hybridizations were performed
as described [30]. Three independent experiments and
RNA extractions were performed and each set of RNAs
was used in one hybridization experiment. The F. tular-
ensis microarrays (obtained from the “Pathogen Func-
tional Genomics Resource Center”,P F G R C )c o n t a i n
70-mer oligonucleotides, in five copies, representing all
genes of strains SchuS4 and LVS. Microarrays were
scanned with a Genepix 4000B scanner (Molecular
Devices). To quantify signal fluorescence intensities,
TIFF images were analyzed using the Genepix Pro 6.0
software. Statistical analyses were performed using pub-
licly available software, the R/Bioconductor package
LIMMA (available from http://www.bioconductor.org).
A list of statistically significant differentially expressed
genes was obtained using lowess normalization (after
inspection of MA plots) and applying the empirical
Bayes moderated t-test. Microarray data are available at
ArrayExpress.
Quantitative real-time RT-PCR
To validate the microarray results, two ORFs were
selected (for each mutant strain) for real-time quantita-
tive reverse transcription PCR (qRT-PCR) analysis with
the same RNA samples used in the microarray hybridi-
zations. For the analyses, one microgram of RNA was
reverse transcribed using random hexamers and Super-
Script II reverse transcriptase (Invitrogen) according to
the protocol provided by the manufacturer. Real-time
PCR was performed with gene-specific primers using an
ABI PRISM 7700 and FastStart SYBR master mix
(Roche Diagnostics). To calculate the amount of gene-
specific transcript, a standard curve was plotted for each
primer set using a series of diluted genomic DNA from
LVS. To compare the transcript amounts in the different
strains, the amounts of each gene transcript was nor-
malized to DNA helicase (FTL_1656) as this gene has
been shown to change little in expression during growth
[23]. The expression of each gene was determined from
three replicates in a single qRT-PCR experiment.
Cell infections
J774 cells were propagated in RPMI or Dulbecco’s Mod-
ified Eagle’sM e d i u m( D M E M )m e d i u mc o n t a i n i n g1 0 %
fetal calf serum. Cells were seeded at a concentration of
~2 × 10
5 cells per well in 12-well tissue plates (Falcon)
and monolayers were used 24 hours after seeding. J774
macrophage monolayers were incubated for 90 min at
37°C with the bacterial suspensions (approximate multi-
plicities of infection 100) to allow the bacteria to enter.
After washing (time zero of the kinetic analysis), the
cells were incubated in fresh culture medium containing
gentamicin (10 μgm l
-1) to kill extracellular bacteria. At
several time-points, cells were washed three times in
PBS and processed for counting of surviving intracellu-
lar bacteria. For this, bacteria were recovered by lysis of
macrophages with distilled water and the titer of viable
bacteria released from the cells was determined by
spreading preparations on agar plates. For each strain
a n dt i m ei na ne x p e r i m e n t ,t h ea s s a yw a sp e r f o r m e d
in triplicate. Each experiment was independently
repeated two times and the data presented are from one
experiment.
Mice infections
LVS and mutant strains were grown in Schaedler-K3 to
exponential growth phase and diluted to the appropriate
concentrations. 6 to 8-week-old female BALB/c mice
(Janvier, Le Genest St Isle, France) were i.p. inoculated
with 200 μl of bacterial suspension. Groups of five mice
were inoculated with various doses of bacteria (approxi-
mately 10
1 to 10
4 bacteria) and the mortality was fol-
lowed for 9 days. The actual number of viable bacteria
in the inoculum was determined by plating dilutions of
the bacterial suspension on chocolate plates. For compe-
titive infections, LVS and mutant bacteria were mixed in
1:1 ratio and a total of approximately 400 bacteria were
used for infection of five mice. After four days, mice
were sacrificed. Homogenized spleen tissue from the
five mice in one experiment were mixed, diluted and
spread onto chocolate agar plates. PCR to distinguish
wild-type and mutant bacteria were performed on 100
colonies. Animal experiments were performed according
Postic et al. BMC Genomics 2010, 11:625
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Page 10 of 12to the INSERM guidelines for laboratory animals’
husbandry.
Additional material
Additional file 1: Quantitative RT-PCR confirms the microarray
results. Transcript levels of selected genes were normalized to that of
DNA helicase (FTL_1656) and the fold difference (in mutant strain relative
to wild-type strain) and standard deviations are shown for the FTL_0045
and FTL_1922 genes (ftrA mutant) and FTL_0421 and FTL_0836 genes
(ftrB mutant).
Additional file 2: Putative sRNAs predicted in silico. Table contains
data provided in Table 3 in the text and the sequences of each of the
predicted RNAs.
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